Lynch Syndrome: Clinical Trials

5 trials for Lynch Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Lynch Syndrome: new trials by email Literature Review of Lynch Syndrome trials Research Report on Lynch Syndrome

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers
Arm A: DC vaccination, Arm B: Placebo vaccination - Lynch Syndrome
Phase 3Not yet recruitingRadboud University Medical Center3722026-10-012026-05-27
PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
PD-1 Antibody - Lynch Syndrome
Phase 3UnknownSun Yat-sen University2602020-11-012021-01-20
Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
Acetylsalicylic acid lysinate 300 mg, Placebo (for Aspirin 300), Acetylsalicylic acid lysinate 100 mg - Lynch Syndrome
Phase 3Active not recruitingAssistance Publique - Hôpitaux de Paris8522017-11-142025-07-08
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Atezolizumab, Biospecimen Collection, Computed Tomography - Colon Adenocarcinoma, DNA Repair Disorder
Phase 3Active not recruitingNational Cancer Institute (NCI)7122017-10-162026-11-13
The Cancer of the Pancreas Screening-5 CAPS5)Study
Secretin, MRI, Tumor marker gene test with CA19-9 - Pancreas Cancer, Peutz-Jeghers Syndrome (PJS)
Phase 3RecruitingJohns Hopkins University90002014-01-062026-10-22

Narrower conditions

Colorectal Neoplasms, Hereditary Nonpolyposis (5)  ·  Breast Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  DNA Repair-Deficiency Disorders (1)  ·  Dysplastic Nevus Syndrome (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Hereditary pancreatitis (1)  ·  Pancreatic Neoplasms (1)  ·  Peutz-Jeghers Syndrome (1)

Broader conditions

Colonic Diseases (5)  ·  Colorectal Neoplasms (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)  ·  Genetic Diseases, Inborn (5)  ·  Intestinal Diseases (5)  ·  Intestinal Neoplasms (5)  ·  Metabolic Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Neoplastic Syndromes, Hereditary (5)  ·  Nutritional and Metabolic Diseases (5)

Interventions

CA-19-9 Antigen (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Oxaliplatin (1)  ·  Secretin (1)  ·  Specimen Handling (1)  ·  acetylsalicylic acid lysinate (1)  ·  atezolizumab (1)  ·  dehydroftorafur (1)  ·  spartalizumab (1)  ·  toripalimab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Johns Hopkins University (1)  ·  National Cancer Institute (NCI) (1)  ·  Radboud University Medical Center (1)  ·  Sun Yat-sen University (1)

Countries

United States (2)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Puerto Rico (1)

Top investigators

Frank A Sinicrope (1)  ·  Michael Goggins, MD (1)  ·  Peirong Ding, MD, Ph D (1)

Results publications

PMID 31197699, PMID 31676359, PMID 32887653, PMID 33161160, PMID 34149034, PMID 40953502, PMID 41880612

NIH funding

R01CA176828 (1), U01CA210170 (1), U10CA180821 (1)